Uncovering the metabolomic fingerprint of breast cancer
- 31 July 2011
- journal article
- review article
- Published by Elsevier BV in The International Journal of Biochemistry & Cell Biology
- Vol. 43 (7), 1010-1020
- https://doi.org/10.1016/j.biocel.2010.05.001
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative1H MR SpectroscopyRadiology, 2009
- The Metabonomic Signature of Celiac DiseaseJournal of Proteome Research, 2008
- Evidence of different metabolic phenotypes in humansProceedings of the National Academy of Sciences of the United States of America, 2008
- MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone statusBreast Cancer Research and Treatment, 2006
- Metabolomic analysis using optimized NMR and statistical methodsAnalytical Biochemistry, 2006
- Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cellsMolecular Cancer Therapeutics, 2006
- Magnetic Resonance Spectroscopy Monitoring of Mitogen-Activated Protein Kinase Signaling InhibitionCancer Research, 2005
- Metabolic targeted therapy of cancer: current tracer technologies and future drug design strategies in the old metabolic networkMetabolomics, 2005
- NMR-based metabonomic approaches for evaluating physiological influences on biofluid compositionNMR in Biomedicine, 2004
- Visualizing metabolic changes in breast‐cancer tissue using 1H‐NMR spectroscopy and self‐organizing mapsNMR in Biomedicine, 2003